Clinical Trial Update: A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover Markers [Phase 4]

View source ↗

Summary

A one-year, randomized trial compares pioglitazone versus linagliptin to assess their impact on bone turnover markers in individuals with osteoporosis and diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Osteoporosis

Drugs mentioned

• Linagliptin (linagliptin)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Osteoporosis, Diabetes Mellitus | Phase 4 | Status: UNKNOWN